Revolution Medicines Inc. (NASDAQ:RVMD) saw a downside of -1.15% to $30.15 after subtracting -$0.35on Wednesday. The 5-day average trading volume is 520,997 shares of the company’s common stock. It has gained $31.00 in the past week and touched a new high 3 times within the past 5 days. An average of 1,200,064 shares of the company has been traded in the last 20 days, and the 50-day average volume stands at 1,050,794.
RVMD’s 1-month performance is 17.09% or $3.62 on its low of $24.61 reached on 08/01/23. The company’s shares have touched a 52-week low of $17.03 and high of $33.19, with the stock’s rally to the 52-week high happening on 08/03/23. YTD, RVMD has achieved 26.57% or $6.57 and has reached a new high 7 times. However, the current price is down -9.16% from the 52-week high price.
Top 5 AI Stocks to Buy for 2023
The artificial intelligence (AI) revolution is already here. And it's about to change everything we know about everything.
According to Grand View Research, the global AI boom could grow from about $137 billion in 2022 to more than $1.81 trillion by 2030. And investors like you always want to get in on the hottest stocks of tomorrow. Here are five of the best ways to profit from the AI boom.
Click Here to Download the FREE Report.
Sponsored
Insider Transactions
RVMD stock investors last saw insider trading activity on Aug 15.Horn Margaret A (Chief Operating Officer) most recently sold 5,000 shares at $30.53 per share on Aug 15. This transaction cost the insider $152,632. Kelsey Stephen Michael, sold 16,666 shares at a price of $32.40 on Aug 02. Then, on Aug 01 Kelsey Stephen Michael sold 16,666 shares at a price of $29.19 per share. This transaction amounted to $486,502.
Valuation Metrics
RVMD stock has a beta of 1.33. Moving on to other valuation ratios, the trailing price-to-sales (P/S) ratio is 110.33 while the price-to-book (PB) in the most recent quarter is 3.46.
Revolution Medicines Inc.’s quick ratio for the period ended June 29 was 11.80, with the current ratio over the same period at 11.80. The trailing 12-month EBITDA margin is -702.72%. The firm’s gross profit as reported stood at $293.66 million against revenue of $35.38 million.
Earnings Surprise
For the quarterly period ending June 29 this year, Net income and sales went down compared to those figures reported in the previous quarter. Net income grew 37.72% to -$98.3 million, while revenue of -$68.1 million was 30.72% off the previous quarter. Analysts expected RVMD to announce -$0.82 per share in earnings in its latest quarter, but it posted -$0.92, representing a -12.20% surprise. EBITDA for the quarter stood at more than -$111.88 million. RVMD stock balance sheet for the quarter ending June 29 shows that total liabilities totaled 142.87 million, with total debt at $63.26 million. Shareholders hold equity totaling $109.17 million.
Let’s look briefly at Revolution Medicines Inc. (RVMD) price momentum from a technical analysis perspective. The 9-day relative strength index as at close on 22 August was 58.69% to suggest the stock is trending Neutral, with historical volatility in this time period at 25.28%.
The stock’s 5-day moving average is $29.93, reflecting a +1.64% or $0.49 change from its current price. RVMD is currently trading +20.07% above its 20-day SMA, +41.61% above its 100-day SMA. However, the stock’s current price level is away from the SMA50 by +20.07% and SMA200 by+47.52%.
Stochastic %K and %D was 32.57% and 38.55% and the average true range (ATR) pointed at 1.09. The RSI (14) points at 58.77%, while the 14-day stochastic is at 40.82% with the period’s ATR at 1.13. The stock’s 9-day MACD Oscillator is pointing at 0.22 and 0.20 on the 14-day charts.
Analyst Ratings
In the most recent analyst report for Revolution Medicines Inc. (NASDAQ: RVMD), JP Morgan upgraded it to an Overweight rating. They previously had a Neutral rating on the stock. Analysts offering their rating for RVMD stock have a consensus rating for the stock as Buy. Currently, 0 brokerage advisors rate RVMD as a “sell,”, while 1 advise that investors “Hold.” 0 analysts have rated the stock as underweight. 0 rates the stock as overweight while 7 have offered a “buy” rating.
What is RVMD’s price target for the next 12 months?
Analysts have a consensus price target ranging from a low of $30.00 and a high of $40.00, with their median price target at $34.00. Looking at these predictions, the average price target given by analysts is for Revolution Medicines Inc. (RVMD) stock is $34.14.
